2025-12-28 - Analysis Report
Here's a comprehensive analysis of Honeywell International Inc. (HON) based on the provided data:

**0) Report Summary**

*   **Performance:** HON has significantly underperformed the S&P 500 (VOO) in cumulative return.
*   **Risk:** Market risk indicators suggest a favorable investment climate.
*   **Technicals:** HON is trading slightly above its 5-day and 20-day SMAs, but below its 60-day SMA, indicating mixed short-term momentum.
*   **Analyst Sentiment:** Analysts generally have a "Buy" rating on the stock with a target price significantly above the current price.
*   **Earnings:** Recent earnings have been positive, with consistent revenue growth and strong profit margins.
*   **Financials:** ROE is healthy.

**1) Return Comparison and Divergence**

*   **HON Company Overview:** Honeywell International Inc. is a diversified technology and manufacturing company serving customers worldwide with aerospace products and services, control technologies for buildings and industry, and performance materials.
*   **HON Cumulative Return:** 8.43%
*   **S&P 500 (VOO) Cumulative Return:** 103.21%
*   **Divergence:** -91.5 (Relative Divergence: 4.8)

**Analysis:** HON has drastically underperformed the S&P 500 over the period reflected in the cumulative returns. The divergence of -91.5 indicates a significant gap in performance. The relative divergence of 4.8 suggests this divergence is near the low end of its historical range.

**Alpha, Beta Analysis:**

*   **CAGR:** Shows the compound annual growth rate. Fluctuates significantly, with a recent decline.
*   **MDD:** Represents the Maximum Drawdown, a measure of downside risk. Consistently high, indicating significant potential for losses from peak to trough.
*   **Alpha:** Measures performance relative to a benchmark (S&P 500). Negative Alpha values in recent periods indicate underperformance compared to the market.
*   **Beta:** Measures volatility relative to the market. Beta consistently above 1 suggests HON is more volatile than the S&P 500.
*   **Cap(B):** Market Capitalization in Billions.

**Analysis:** The table highlights a concerning trend. While Honeywell's market capitalization has generally increased, the company's CAGR has deteriorated, and Alpha has become increasingly negative, especially in the most recent periods. This suggests the company is not generating the returns commensurate with its size and that it is underperforming the market. High MDD values indicate significant risk.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 197.37
*   **Last-Market Change:** +0.22 (from 196.93)
*   **5-day SMA:** 196.974
*   **20-day SMA:** 194.75
*   **60-day SMA:** 199.332

**Analysis:** The stock is trading slightly above its 5-day and 20-day moving averages but below its 60-day moving average. This suggests a mixed short-term trend, with potential for further volatility. The small change in the last market indicates relatively stable recent trading.

**3) RSI, PPO, and Expected Return**

*   **MRI:** 1.0 (High Investment Recommended)
*   **RSI:** 64.45
*   **PPO:** 0.3136
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (5 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)"
*   **Recent Relative Divergence Change:** +2.5 (Short-term increase)
*   **Expected Return:** -625.4%

**Analysis:** The MRI indicates a generally favorable market environment. The RSI of 64.45 is approaching overbought territory but is not yet at an extreme level. The PPO is positive, indicating bullish momentum, albeit modest. The Hybrid Signal suggests a "Buy" recommendation. The Recent Relative Divergence Change indicates a recent short-term increase in relative performance. However, the extremely negative Expected Return is a *major red flag*. This suggests significant downside risk and potential underperformance relative to the S&P 500 over the long term, contradicting the MRI’s suggestion.

**4) Recent News & Significant Events**

*   **Honeywell International Inc. $HON Stock Holdings Lessened by Meyer Handelman Co.**
*   **Honeywell International Inc. (HON) Stock Sinks As Market Gains**
*   **HON Stock vs. 3M: Which Industrial Giant Looks Stronger in 2025**
*   **Honeywell (HON) Stock: What to Know Before the U.S. Market Opens on Dec. 26, 2025**
*   **Honeywell Stock Tumbles on Potential $470M Settlement**
*   **Opinion: Quantum computing is the stock market’s next big tech play — and these stocks are still cheap**

**Analysis:** The news headlines paint a mixed picture. Some articles focus on underperformance ("Sinks As Market Gains"), while others compare it to competitors or highlight factors to consider before investing. The "Tumbles on Potential $470M Settlement" headline is particularly concerning as it indicates a potential liability that could negatively impact the stock price.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.07)
*   **Target Price:** $236.61 (Avg), $271.00 (High), $195.00 (Low)

**Analysis:** Analyst sentiment is generally positive, with a "Buy" consensus and a target price significantly above the current price. However, the range between the high and low target prices is wide, indicating some uncertainty among analysts.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-10-23 | 2.87 | 10.41 B$      |
| 2025-07-24 | 2.46 | 10.35 B$      |
| 2025-04-29 | 2.24 | 9.82 B$      |
| 2024-10-24 | 2.17 | 9.73 B$      |
| 2025-10-23 | 2.17 | 9.73 B$      |

**Analysis:** Both EPS and Revenue have been generally increasing over the reported periods. This positive trend suggests healthy business performance. The sudden duplication of figures is suspicious and needs verification against other source data.

**6) Financial Information**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30 | $10.41B  | 34.08%        |
| 2025-06-30 | $10.35B  | 38.86%        |
| 2025-03-31 | $9.82B   | 38.54%        |
| 2024-12-31 | $10.09B  | 36.38%        |
| 2024-09-30 | $9.73B   | 38.54%        |

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-09-30 | $16.78B   | 10.87%   |
| 2025-06-30 | $16.09B   | 9.75%    |
| 2025-03-31 | $17.46B   | 8.30%    |
| 2024-12-31 | $18.62B   | 6.90%    |
| 2024-09-30 | $17.41B   | 8.12%    |

**Analysis:** Revenue has generally increased, indicating positive sales growth. Profit margins are consistently strong, suggesting efficient operations and pricing power. Return on Equity (ROE) is fluctuating but remains generally healthy, indicating that the company is effectively using its equity to generate profits.

**7) Comprehensive Analysis (Summary)**

Based on the provided data, Honeywell (HON) presents a mixed investment picture:

*   **Negative Factors:**
    *   **Significant Underperformance:** HON has vastly underperformed the S&P 500.
    *   **Negative Expected Return:** The calculated expected return of -625.4% is a *major* warning sign. This contradicts the high MRI. This discrepancy needs investigation.
    *   **Settlement Risk:** The news of a potential $470M settlement is a concern.
    *   **Decreasing CAGR and Increasing Negative Alpha** in recent periods.
    *   **High MDD** indicates significant potential for losses.
*   **Positive Factors:**
    *   **Positive Analyst Sentiment:** Analysts generally rate the stock a "Buy" with a higher target price.
    *   **Healthy Earnings and Revenue Growth:** Recent earnings reports show increasing EPS and revenue.
    *   **Strong Profit Margins:** Consistent profit margins indicate efficient operations.
    *   **Positive ROE:** Indicates efficient use of equity to generate profits.
    *   **High MRI**: Suggests a favorable market environment.

**Conclusion:**

The data suggests that investing in HON is risky. While analysts are generally positive and the company demonstrates solid financial performance in terms of earnings, revenue, profit margins, and ROE, the significant underperformance relative to the S&P 500, the extremely negative expected return, and news of potential settlements raise serious concerns. The high maximum drawdown further reinforces the downside risks.

**Recommendation:**

**Due to the contradictory signals (high MRI vs. negative Expected Return) and the recent history of underperformance, a very cautious approach is warranted.** A potential investor should:

1.  **Investigate the Discrepancy:** Thoroughly investigate the source of the highly negative "Expected Return" figure and understand why it contradicts the positive Market Risk Indicator (MRI). Verify the calculation and the underlying assumptions.
2.  **Assess the Settlement Risk:** Understand the details and potential impact of the $470M settlement.
3.  **Re-evaluate Analyst Opinions:** Consider the wide range in analyst target prices and understand the basis for their recommendations.
4.  **Compare to Alternatives:** Compare HON to other industrial giants (as in the Forbes article) to assess relative value.
5.  **Consider a Smaller Position:** If, after further investigation, the negative factors are mitigated, consider a very small, speculative position in HON.

**Without a clear understanding of the negative Expected Return, investing in HON is not advisable.** The high risk factors outweigh the positive financial indicators and analyst sentiment.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.